Nerve growth factor supplementation reverses the impairment, induced by Type 1 diabetes, of hindlimb post-ischaemic recovery in mice

Keyphrases

• Type 1 Diabetes Mellitus (T1DM) 100%
• Hindlimb 100%
• Type I Diabetes 100%
• Nerve Growth Factor 100%
• Apoptosis 25%
• High Glucose 25%
• Diabetic Mice 25%
• Vascular Endothelial Growth Factor 25%
• Type 1 Diabetic 25%
• Endothelial Cells 16%
• Diabetes 16%
• Ischemia 16%
• Blood Flow 16%
• Neovascularization 16%
• Factor Content 16%
• Adductor 16%
• Endothelial Dysfunction 8%
• Diabetes Complications 8%
• Healing 8%
• Diabetic Animals 8%
• Therapeutic Potential 8%
• Induced Apoptosis 8%
• Non-diabetic 8%
• Endothelial Cell Apoptosis 8%
• Receptor Expression 8%
• Arteriogenesis 8%
• Beneficial Effects 8%
• Human Endothelial Cells 8%
• Angiogenesis 8%
• Microvessel Density 8%
• New Therapeutics 8%
• Healing Process 8%
• System Components 8%
• Necropsy 8%
• Streptozotocin-induced 8%
• Hindlimb Ischemia 8%
• P75 Neurotrophin Receptor (p75NTR) 8%
• Capillarization 8%
• Peripheral Ischemia 8%
• Factor System 8%
• Limb Ischemia 8%
• Flow Recovery 8%
• Nerve Growth Factor Receptor 8%

Medicine and Dentistry

• Supplementation 100%
• Insulin Dependent Diabetes Mellitus 100%
• Hindlimb 100%
• Nerve Growth Factor 100%
• Programmed Cell Death 41%
• Endothelial Cell 33%
• Ischemia 25%
• Vasculotropin A 25%
• Diabetes Mellitus 16%
• Diabetes 16%
• Blood Flow 16%
• Upregulation 8%
• In Vitro 8%
• Complications of Diabetes Mellitus 8%
• Enzyme Linked Immunosorbent Assay 8%
• Streptozocin 8%
• Receptor 8%
• Microvessel 8%
• Glucose 8%
• Endothelial Dysfunction 8%
• Angiogenesis 8%
• Receptor Expression 8%
• Arteriogenesis 8%
• Limb Ischemia 8%
• Peripheral Ischemia 8%
• Nerve Growth Factor Receptor 8%

Neuroscience

• Nerve Growth Factor 100%
• Ischemia 41%
• Diabetes Mellitus 25%
• Vasculotropin A 25%
• Eicosanoid Receptor 8%
• Streptozotocin 8%
• In Vitro 8%
• Microvessel 8%
• Glucose 8%
• Receptor Expression 8%
• ELISA 8%
• Angiogenesis 8%
• Nerve Growth Factor Receptor 8%